Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Asthma Clinical Trials

A listing of Asthma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (30) clinical trials

Do You Have Asthma? WCCT Global is seeking adults who have diagnosed with asthma for at least the last 6 months to participate in a clinical research study with an investigational medication. You may receive: Compensation for time and travel Study related care To see if you may qualify call: …

Phase

Do You Suffer From Asthma? WCCT Global is looking for adults who have mild to moderate asthma to participate in a clinical research study with an investigational medication. Participants may receive: Up to $800 for time and travel (11 office visits required) Study related care at no cost Investigational medication …

Phase

Evaluation of Safety and Tolerability of BI 894416 in Patients With Mild Asthma

In both parts, the primary comparisons of interest are between the percentage of patients with drug-related adverse events at each dose and placebo during single and multiple dosing regimens. Based on these, the primary trial objective is to assess safety and tolerability of BI 894416 at each dose. Secondary measures …

Phase

: Vascular Function in Health and Disease

Angiotensin-II (ANG-II) is the end-product of the renin-angiotensin cascade, and acts as a potent endogenous vasoconstrictor through binding to the angiotensin receptor (AT1) on arteriolar vascular smooth muscle. With advancing age, there is a notable decline in plasma renin activity accompanied by decrements in circulating ANG-II and an increase in …

Phase

Study of TT-00920 in Healthy Subjects

Part 1: SAD For the SAD part, there will be 5 cohorts (including 1 cohort for food effect assessment). Each subjects per cohort will be enrolled and randomized to assess the safety, tolerability, and PK profile.Safety, tolerability, and PK data for each cohort will be reviewed by the Safety Review …

Phase

A Study to Assess the Pharmacokinetics (PK) Pharmacodynamics (PD) and Safety of 2-Week Treatment With Inhaled AZD7594 in Adolescents (12 to 17 Years) With Asthma

This is an open-label, multi-centre, Phase I study to assess the PK, PD and safety of 2 week treatment with inhaled AZD7594 in adolescent patients with asthma. The study is planned to be conducted at 4-10 study sites in the United States. Eligible 12 to 17-year-old patients with asthma controlled …

Phase

Single and Multiple Ascending Dose Study of TD-8236 by Inhalation

This is a Phase 1, randomized, double-blinded, placebo controlled study. The study consists of 3 parts: Part A is a single ascending dose (SAD) study in healthy subjects, Part B is a multiple ascending dose (MAD) study in subjects with stable, mild asthma, and Part C (Biomarker) is a multiple …

Phase

Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation

The production of chemotactic cytokines or chemokines by the airways is one of the mechanisms thought to be responsible for the recruitment of inflammatory cells to the airways (Makay 2001). While the chemokine receptor-ligand systems responsible for immune cell homing to the mucosal surface of the gastrointestinal tract have been …

Phase

Airway Temperature

A total of eight participants will be enrolled into this study. We will take direct measurements of bronchial mucosa temperature. This can only be tested accurately in asthma participants because anesthesia is known to lower the body temperature. The proposed study using and experimental procedure called a segmental bronchoprovocation challenge …

Phase

Phosphodiesterase 4 Inhibitor Roflumilast and the Effects of Inhibition in Severe Asthma

T2 low asthma is common in obese asthmatics. New evidence suggests that hyperinsulinemia and insulin resistance, both common in obesity, are associated with an increased risk of concurrent asthma. Targeting Phosphodiesterase 4 inhibitors (PDE4) allows for examination of a mechanism potentially linking obesity and asthma as well as identification of …

Phase